Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

Rodriguez, W J

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. [electronic resource] - Pediatrics Mar 1997 - 454-61 p. digital

Publication Type: Clinical Trial; Comment; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

1098-4275

10.1542/peds.99.3.454 doi


Bronchiolitis--complications
Bronchopulmonary Dysplasia--complications
Child, Preschool
Double-Blind Method
Follow-Up Studies
Heart Defects, Congenital--complications
Hospitalization
Humans
Immunoglobulins, Intravenous--therapeutic use
Infant
Infant, Newborn
Infant, Premature
Pneumonia, Viral--complications
Respiratory Syncytial Virus Infections--complications
Respiratory Syncytial Virus, Human--immunology
Risk Factors
Treatment Outcome